Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China

Ophthalmology

Volumn 120, Issue 2, 2013, Pages 355-361

  Wang, Fenghua ^a   Yu, Suqin ^a   Liu, Kun ^a   Chen, Feng E ^a   Song, Zhengyu ^a   Zhang, Xi ^a   Xu, Xun ^a   Sun, Xiaodong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CORTICOSTEROID; COUNTERFEIT DRUG; ENDOTOXIN;

ADULT; AGED; ARTICLE; CHINA; DRUG CONTAMINATION; EYE INFLAMMATION; EYE TOXICITY; FEMALE; HUMAN; HYPOPYON; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VITRECTOMY; VITREOUS DISEASE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHINA; COUNTERFEIT DRUGS; DRUG CONTAMINATION; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; ENDOTOXINS; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETINAL DISEASES; RETROSPECTIVE STUDIES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY; YOUNG ADULT;

EID: 84873306782     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.07.083     Document Type: Article

References (27)

1. CATT Research Group D.F. Martin, M.G. Maguire, G.S. Ying et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
2. R.D. Jager, W.F. Mieler, J.W. Miller Age-related macular degeneration N Engl J Med 358 2008 2606 2617
3. J.C. Folk, E.M. Stone Ranibizumab therapy for neovascular age-related macular degeneration N Engl J Med 363 2010 1648 1655
4. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
5. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
6. Q.D. Nguyen, S.M. Shah, A.A. Khwaja READ-2 Study Group Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study Ophthalmology 117 2010 2146 2151
7. R. Jorge, R.S. Oliveira, A. Messias Ranibizumab for retinal neovascularization [letter] Ophthalmology 118 2011 1004
8. P.A. Campochiaro, D.M. Brown, C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
9. D.M. Brown, P.A. Campochiaro, R.B. Bhisitkul Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
10. C.C. Wykoff, H.W. Flynn Jr Endophthalmitis after intravitreal injection: prevention and management Retina 31 2011 633 635
11. A.A. Moshfeghi, P.J. Rosenfeld, H.W. Flynn Jr Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center Retina 31 2011 662 668
12. C.A. McCannel Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies Retina 31 2011 654 661
13. S. Day, K. Acquah, P. Mruthyunjaya Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration Am J Ophthalmol 152 2011 266 272
14. D.B. Roth, H.W. Flynn Jr Distinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injection Am J Ophthalmol 146 2008 346 347
15. T. Sato, K. Emi, T. Ikeda Severe intraocular inflammation after intravitreal injection of bevacizumab Ophthalmology 117 2010 512 516
16. T. Ness, N. Feltgen, H. Agostini Toxic vitreitis outbreak after intravitreal injection Retina 30 2010 332 338
17. C.P. Shah, S.J. Garg, J.F. Vander Post-Injection Endophthalmitis (PIE) Study Team Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents Ophthalmology 118 2011 2028 2034
18. S.S. Wickremasinghe, K. Michalova, J. Gilhotra Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration Ophthalmology 115 2008 1911 1915
19. X. Sun, X. Xu, X. Zhang Counterfeit bevacizumab and endophthalmitis [letter] N Engl J Med 365 2011 378 379 author reply 379
20. Standardization of Uveitis Nomenclature (SUN) Working Group D.A. Jabs, R.B. Nussenblatt, J.T. Rosenbaum Standardization of uveitis nomenclature for reporting clinical data Results of the First International Workshop Am J Ophthalmol 140 2005 509 516
21. S.P. Holland, R.G. Mathias, D.W. Morck Diffuse lamellar keratitis related to endotoxins released from sterilizer reservoir biofilms Ophthalmology 107 2000 1227 1234
22. P. Maier, F. Birnbaum, D. Bohringer, T. Reinhard Toxic anterior segment syndrome following penetrating keratoplasty Arch Ophthalmol 126 2008 1677 1681
23. F.A. Richburg, J.J. Reidy, D.J. Apple, R.J. Olson Sterile hypopyon secondary to ultrasonic cleaning solution J Cataract Refract Surg 12 1986 248 251
24. L. Trinh, F. Brignole-Baudouin, A. Labbe The corneal endothelium in an endotoxin-induced uveitis model: correlation between in vivo confocal microscopy and immunohistochemistry Mol Vis [serial online] 14 2008 1149 1156 http://www.molvis.org/molvis/v14/a136/ Accessed July 20, 2012
25. L.A. Brito, M. Singh Acceptable levels of endotoxin in vaccine formulations during preclinical research J Pharm Sci 100 2011 34 37
26. S. Gonzalez, P.J. Rosenfeld, M.W. Stewart Avastin doesn't blind people, people blind people Am J Ophthalmol 153 2012 196 203
27. R.A. Goldberg, H.W. Flynn Jr, R.F. Isom An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab Am J Ophthalmol 153 2012 204 208